NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Free peptide testing

Ordered peptides from SRY Labs? Mail in a sample (US only) and let us test it.

Test my supply
+4 more ↓
62%
Finnrick rating
#379 of 457 ranked vendors
86 of 130 classifiable tests passed
methodology · Purity focus
Finnrick analysis

SRY Labs' purity-focus record is strongest in Tirzepatide and Retatrutide, where recent runs mostly pass after earlier misses. Results are dispersed rather than uniform: Tesamorelin and TB-500 show repeated purity or fill problems, while high volume and current testing are offset by frequent batch-ID gaps.

methodology →
vendor intelligence report
Vendor Intelligence Report: SRY Labs

We investigated who actually operates SRY Labs — corporate records, ownership trails, web infrastructure, and how its lab results break down product by product. Read the full report before you order.

28 pages5 risk factors assessed12 Jun 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Tirzepatide
$0.34
92%
36
2
Retatrutide
$0.60
91%
32
3
Ipamorelin
$0.70
75%
4
4
GHK-Cu
-
72%
7
5
Semaglutide
$0.55
65%
4
6
PT-141
$0.60
58%
2
7
Cagrilintide
$1.20
49%
8
8
BPC-157
$0.50
47%
8
10
TB-500
$1.15
35%
9
11
Tesamorelin
-
34%
12
12
CJC-1295
$2.60
33%
5
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%6 Nov 2025: 53%6 Nov 2025: 53%6 Nov 2025: 54%17 Nov 2025: 54%18 Nov 2025: 54%18 Nov 2025: 54%25 Nov 2025: 54%25 Nov 2025: 54%18 Dec 2025: 55%15 Jan 2026: 55%15 Jan 2026: 55%29 Jan 2026: 54%30 Jan 2026: 55%2 Feb 2026: 55%2 Feb 2026: 54%2 Feb 2026: 55%15 Feb 2026: 55%15 Feb 2026: 55%20 Feb 2026: 55%20 Feb 2026: 55%20 Feb 2026: 55%2 Mar 2026: 55%2 Mar 2026: 56%2 Mar 2026: 56%2 Mar 2026: 56%6 Mar 2026: 57%13 Mar 2026: 57%19 Mar 2026: 57%25 Mar 2026: 57%25 Mar 2026: 57%23 Apr 2026: 57%6 May 2026: 57%8 May 2026: 58%8 Jun 2026: 58%20 Jul 2026: 58%15 Sep 2026: 58%15 Sep 2026: 59%15 Sep 2026: 60%15 Sep 2026: 60%24 Sep 2026: 60%7 Oct 2026: current 62%53%56%62%Nov 25Oct 26
Free peptide testing

Ordered peptides from SRY Labs? Mail in a sample (US only) and let us test it.

Test my supply
SRY Labs test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
24 Sep 2026
Pass
Retatrutide
lab nameView COA
15 Sep 2026
Fail
TB-500
lab nameView COA
15 Sep 2026
Pass
Ipamorelin
lab nameView COA
15 Sep 2026
Pass
BPC-157
lab nameView COA
15 Sep 2026
Pass
CJC-1295 (No DAC)
lab nameView COA
20 Jul 2026
Pass
Tirzepatide
lab nameView COA
8 Jun 2026
Pass
Retatrutide
lab nameView COA
8 May 2026
Pass
Cagrilintide
lab nameView COA
6 May 2026
Pass
Tirzepatide
lab nameView COA
23 Apr 2026
Pass
Tirzepatide
lab nameView COA
1-10 of 130

About SRY Labs test results from Finnrick

SRY Labs is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 12 peptides and 130 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible SRY Labs peptides in this dataset are Tirzepatide (36 tests) and Retatrutide (32 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 130 recent tests.

Corrections
No corrections.
Free peptide testing

Ordered peptides from SRY Labs? Mail in a sample (US only) and let us test it.

Test my supply